APA (7th ed.) Citation

Zumla, A. I., Gillespie, S. H., Hoelscher, M., Philips, P. P. J., Cole, S. T., Abubakar, I., . . . Nunn, A. J. (2014). New antituberculosis drugs, regimens, and adjunct therapies: Needs, advances, and future prospects. The Lancet infectious diseases, 14(4), 327-340. https://doi.org/10.1016/S1473-3099(13)70328-1

Chicago Style (17th ed.) Citation

Zumla, Alimuddin I., et al. "New Antituberculosis Drugs, Regimens, and Adjunct Therapies: Needs, Advances, and Future Prospects." The Lancet Infectious Diseases 14, no. 4 (2014): 327-340. https://doi.org/10.1016/S1473-3099(13)70328-1.

MLA (9th ed.) Citation

Zumla, Alimuddin I., et al. "New Antituberculosis Drugs, Regimens, and Adjunct Therapies: Needs, Advances, and Future Prospects." The Lancet Infectious Diseases, vol. 14, no. 4, 2014, pp. 327-340, https://doi.org/10.1016/S1473-3099(13)70328-1.